Interpretative commenting: A tool for improving the laboratory-clinical interface

Clinica Chimica Acta

Volumn 404, Issue 1, 2009, Pages 46-51

  Plebani, Mario ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Clinical audit; Communication of laboratory data; External quality assurance schemes; Interpretative comments; Laboratory results; Safety; Training and education

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL LABORATORY; HUMAN; LABORATORY TEST; MEDICAL AUDIT; MEDICAL ERROR; MEDICAL PROFESSION; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; TRAINING; VOCATIONAL EDUCATION;

CLINICAL CHEMISTRY TESTS; HUMANS; MEDICAL ERRORS; QUALITY ASSURANCE, HEALTH CARE; SAFETY MANAGEMENT;

EID: 67349202304     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.03.012     Document Type: Article

References (66)

1. Donaldson L. Foreword. Clin Chem Lab Med 45 (2007) 697-699
2. Kohn K.T., Corrigan J.M., and Donaldson M.S. To err is human: building a safer health system (1999), National Academy Press, Washington, DC
3. Department of Health. An organisation with a memory: report of an expert group on learning from adverse events in the NHS chaired by the Chief Medical Officer (2000), HMSO, London
4. Blendon R.J., DesRoches C.M., and Brodie M. Views of practicing physicians and the public on medical errors. N Engl J Med 347 (2002) 1933-1940
5. Phillips Jr. R.L., Bartholomew L.A., and Dovey S.M. Learning from malpractice claims about negligent, adverse events in primary care in the United States. Qual Saf Health Care 13 (2004) 121-126
6. A. Chandra, S. Nundy, S.A. Seabury. The growth of physician medical malpractice payments: evidence from the national practitioner data bank. Health Aff (Millwood). 2005; Suppl Web Exclusives: W5-240-W5-249.
7. Graber M.L., Franklin N., and Gordon R. Diagnostic error in internal medicine. Arch Intern Med 165 (2005) 1493-1499
8. Hickner J., Graham D.G., Elder N.C., et al. Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network. Qual Saf Health Care 17 (2008) 194-200
9. Gandhi T.K., Kachalia A., Thomas E.J., et al. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern med 145 (2006) 488-496
10. Wahls T.L., and Cram P.M. The frequency of missed test results and associated treatment delays in a highly computerized health system. BMC Fam Pract 8 (2007) 32-42
11. Kachalia A., Gandhi T.K., Pupolo A.L., et al. Missed and delayed diagnoses in the Emergency department: a study of closed malpractice claims from 4 liability insurers. Ann Emerg Med 49 (2007) 196-205
12. Plebani M. Errors in laboratory medicine and patient safety: the road ahead. Clin Chem Lab Med 45 (2007) 700-707
13. Kilpatrick E.S., and Holding S. Use of computer terminals on wards to access emergency test results: a retrospective audit. BMJ 322 (2001) 1101-1103
14. Howanitz J.H., and Howanitz P.J. Evaluation of total serum calcium critical values. Arch Pathol Lab Med 130 (2006) 828-830
15. Schiff G.D., Kim S., Kronjar N., et al. Missed hypothyroidism diagnosis uncovered by linking laboratory and pharmacy data. Arch Int Med 165 (2005) 574-577
16. Schiff G.D., Aggarwal H.C., Kumar S., and McNutt R.A. Prescribing potassium despite hyperkalemia: medication errors uncovered by linking laboratory and pharmacy information systems. Am J Med 109 (2000) 494-497
17. Waise A., and Plebani M. Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome?. Ann Clin Biochem 38 (2001) 589-595
18. Lundberg G.D. Acting on significant laboratory results. JAMA 245 (1981) 1762-1763
19. Lundberg G.D. The need for an outcome research agenda for clinical laboratory testing. JAMA 280 (1998) 565-566
20. Jones G.R.D. Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error. Med J Aust 186 (2007) 420-421
21. Zardo L., Secchiero S., Sciacovelli L., Bonvicini P., and Plebani M. Reference intervals: are interlaboratory differences appropriate?. Clin Chem Lab Med 37 (1999) 1131-1133
22. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
23. Ridker P.M., and Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 109 (2004) 1955-1959
24. Plebani M. What information on quality specifications should be communicated to clinicians, and how?. Clin Chim Acta 34 (2004) 25-35
25. Plebani M. Quality specifications: self pleasure for clinical laboratories or added value for patient management?. Clin Chem Lab Med 45 (2007) 462-466
26. Challand G.S. Assessing the quality of comments on reports: a retrospective study. Ann Clin Biochem 36 (1999) 316-322
27. Rabsztyn A., Green P.H., Berti I., Fasano A., Perman J.A., and Horvath K. Macroamylasemia in patients with celiac disease. Am J Gastroenterol 96 (2001) 1096-1100
28. Fahie-Wilson M., Bieglmayer C., Kratzsch J., et al. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. Clin Lab 53 (2007) 485-492
29. Ross H.A., Menheere P.P., et al., (on behalf of the Endocrinology Section of SKML [Dutch Foundation for Quality Assessment in Clinical Laboratories]). Interference from heterophilic antibodies in seven current TSH assays. Ann Clin Biochem 45 (2008) 616-618
30. Plebani M., and Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta 381 (2007) 39-49
31. Li P., and Challand G.S. Experience with assessing the quality of comments on clinical biochemistry reports. Ann Clin Biochem 36 (1999) 759-765
32. Marshall W.J., and Challand G.S. Provision of interpretative comments on biochemical report forms. Ann Clin Biochem 37 (2000) 758-763
33. The Royal College of Pathologists. Guidelines for the provision of interpretative comments on biochemical reports. Bull R Coll Pathol 104 (1998) 25
34. Lim E.M., Sikaris K.A., Gill J., et al. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem 50 (2004) 632-637
35. Tonutti E., Visentini D., and Bizzaro N. Interpretative comments on autoantibody tests. Autoimmun Rev 6 (2007) 341-346
36. Wong R.C., Favaloro E.J., Adeslstein S., et al. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology 40 (2008) 58-63
37. Plebani M. Patient safety focus: decreasing postanalytical errors with interpretive reports. Clin Chem Lab News 34 10 (2008) 23. http://www.org/publications/cln/october/Pages/default.aspx (available at www.org/publications/cln/october/Pages/default.aspx) (accessed on November 20, 2008)
38. Walley T. Evaluating laboratory diagnostic tests. BMJ 336 (2008) 569-570
39. Melzer D., Hogarth S., Liddel K., et al. Genetic tests for common diseases: new insights, old concerns. BMJ 336 (2008) 590-593
40. Laposata M.E., Laposata M., Van Cott E.M., et al. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 128 (2004) 1424-1427
41. Barlow I.M. Are biochemistry interpretative comments helpful? Results of a general practitioner and nurse practitioner survey. Ann Clin Biochem 45 (2007) 88-90
42. Plebani M. Total quality in laboratory medicine: the case of haematology and coagulation testing. Int Jnl Lab Hem 29 suppl.1 (2007) 36 (abstract)
43. Kilpatrick E.S. Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine. Ann Clin Biochem 41 (2004) 227-229
44. Cunney R., Aziz H.A., Schubert D., McNamara E., and Smyth E. Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. J Antimicrob Chemother 45 (2000) 705-708
45. ISO 15189: 2007. Medical laboratories - Particular requirements for quality and competence.
46. Clinical Pathology Accreditation (UK). Standards for the Medical Laboratories, version 2.00 (September 2007) www.cpa-uk.co.uk (accessed on September 23rd, 2008).
47. Wong R.C., Gillis D., Adelstein S., et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 36 (2004) 63-68
48. Sturgeon C.M., Hoffman B.R., Chan D.W., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. Clin Chem 54 (2008) e1-e10
49. Poon E.G., Gandhi T.K., Sequist T., et al. I wish I had seen this test result earlier!. Arch Intern Med 164 (2004) 2223-2228
50. Risk Management Foundation. Reducing office practice risks. Forum 20 (2000) 2
51. Boohaker E.A., Ward R.E., Uman J.E., and McCarthy B.D. Patient notification and follow-up of abnormal test results: a physician survey. Arch Intern Med 156 (1996) 327-331
52. Plebani M., Ceriotti F., Messeri G., Ottomano C., Pansini N., and Bonini P. Laboratory network of excellence: enhancing patient safety and services effectiveness. Clin Chem Lab Med 44 (2006) 150-160
53. Sebastiani G., Vario A., Guido M., et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis. J Hepatol 44 (2006) 686-693
54. Sipponen P., Ranta P., Helske T., et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: and observation case-control study. Scand J Gastroenterol 37 (2002) 785-791
55. Laposata M. Patient-specific narrative interpretations of complex clinical laboratory evaluation: who is competent to provide them?. Clin Chem 50 (2004) 471-472
56. Laposata M., and Dighe A. "Pre-pre" and "post-post" analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med 45 (2007) 712-718
57. Carraro P., and Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 53 (2007) 1338-1342
58. Plebani M. Errors in clinical laboratories or errors in laboratory medicine?. Clin Chem Lab Med 44 (2006) 750-759
59. Plebani M. Errors in laboratory medicine and patient safety: the road ahead. Clin Chem Lab Med 45 (2007) 700-707
60. Lim E.M., Vasirakan S.D., Gill J., et al. A discussion of cases in the 2001 RCPA-AQAP Chemical Pathology Case Report comments program. Pathology 35 (2003) 145-150
61. Vasikaran S.D., Penbertthy L., Gill J., Scott S., and Sikaris K.A. Review of a pilot quality-assessment program for interpretative comments. Ann Clin Biochem 39 (2002) 250-260
62. Challand G.S., and Vasikaran S.D. The assessment of interpretation in clinical biochemistry: a personal view. Ann Clin Biochem 44 (2007) 101-105
63. Sciacovelli L., Zardo L., Secchiero S., Zaninotto M., and Plebani M. Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness. Clin Chim Acta 333 (2003) 2019-19
64. Kay J. Technology to improve quality and accountability. Clin Chem Lab Med 44 (2006) 719-723
65. Plebani M., and Laposata M. Translational research involving new biomarkers of disease. A leading role for pathologists. AJCP 126 (2006) 169-171
66. Plebani M., and Marincola F.M. Research translation: a new frontier for clinical laboratories. Clin Chem Lab Med 44 (2006) 1303-1312